Innovation and Drug Pricing: Interview with Dr. Jonathan Darrow

On September 14, 2022, Henri Mattila was joined by Dr. Jonathan Darrow for a broad-ranging conversation on U.S. drug pricing policy and its tentative relationship with the country's leading status as a biopharmaceutical innovator. Dr. Darrow is an assistant professor at Harvard Medical School and a faculty member at the school's Center for Bioethics. Prior to that, he served as a senior law clerk at the U.S. Court of Appeals for the Federal Circuit and has worked in private practice at the law firms Cooley LLP and Wiley Rein LLP. 00:00 Intro 06:28 Interview